Cynosure Advisors’s Labcorp LH Stock Holding History

Cynosure Advisors’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-2,863	Closed	-$442K	–	116
2018 Q2	$442K	Hold	2,863	–	–	0.12%	121
2018 Q1	$398K	Buy	2,863 +32	+1%	+$4.7K	0.1%	131
2017 Q4	$388K	Buy	+2,831	New	+$374K	0.09%	153

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cynosure Advisors's LH Position: Q3 2018 in Review

Cynosure Advisors sold out of Labcorp (LH) in Q3 2018, closing a stake of 2,863 shares — an estimated $442K sold.

Cynosure Advisors first reported a position in LH in Q4 2017 and held it in 3 quarters. The position peaked at $442K in Q2 2018. 793 funds tracked by Wall St. Rank hold LH as of Q3 2018.

Cynosure Advisors reported no remaining Labcorp position as of Q3 2018 after selling out during the quarter.
Cynosure Advisors sold 2,863 Labcorp shares in Q3 2018, an estimated $442K.
Cynosure Advisors first reported a position in Labcorp in Q4 2017 and held it in 3 quarters.
Cynosure Advisors's Labcorp position peaked at $442K in Q2 2018.
793 funds tracked by Wall St. Rank held Labcorp as of Q3 2018.

Based on Cynosure Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.